Author

Yoshimi Iwayama

RIKEN Center for Brain SciencePrimary ORCID profile (0000-0002-7904-6938 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yoshimi IwayamaiD2 papers · Institute of Science Tokyo

Biology Disciplines

Click to filter author papers

Genetics· 2 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Organism:mouse· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:GWAS / association mapping· 1 Assay:metabolomics· 1

Frequent Co-Authors

Takeo YoshikawaiD· 3 shared Akiko Watanabe· 2 shared Chie Shimamoto‐MitsuyamaiD· 2 shared Hisako Ohba· 2 shared Manabu ToyoshimaiD· 2 shared Motoko MaekawaiD· 2 shared Shabeesh BalaniD· 2 shared Tetsuo OhnishiiD· 2 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetics

Takeo YoshikawaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Role of an atypical cadherin gene, Cdh23 in prepulse inhibition and its implication in schizophrenia

Shabeesh Balan, Tetsuo Ohnishi, Akiko Watanabe, Hisako Ohba, Yoshimi Iwayama, Manabu Toyoshima, Tomonori Hara, Yasuko Hisano, Yuki Miyasaka, Tomoko Toyota, Chie Shimamoto‐Mitsuyama, Motoko Maekawa, Shusuke Numata, Tetsuro Ohmori, Tomomi Shimogori, , Takeo Yoshikawa

The paper identifies a Cdh23 variant associated with prepulse inhibition and schizophrenia risk in mice and humans.

Schizophrenia Bulletin · Jan 14, 2021Peer-reviewedGenetics

Genetic risks of schizophrenia identified in a matched case-control study

Kengo Oishi, Tomihisa Niitsu, Nobuhisa Kanahara, Yasunori Sato, Yoshimi Iwayama, Tomoko Toyota, Tasuku Hashimoto, Tsuyoshi Goto Sasaki, Masayuki Takase, Akihiro Shiina, Takeo Yoshikawa, Masaomi Iyo

The paper validates associations between combinations of dopaminergic gene polymorphisms and schizophrenia risk in a matched case-control study.

European Archives of Psychiatry and Clinical Neuroscience · Jul 4, 2020Peer-reviewedGenetics

Investigation of betaine as a novel psychotherapeutic for schizophrenia

Tetsuo Ohnishi, Shabeesh Balan, Manabu Toyoshima, Motoko Maekawa, Hisako Ohba, Akiko Watanabe, Yoshimi Iwayama, Yūkō Fujita, Yunfei Tan, Yasuko Hisano, Chie Shimamoto‐Mitsuyama, Yayoi Nozaki, Kayoko Esaki, Atsuko Nagaoka, Junya Matsumoto, , Takeo Yoshikawa

This study investigates betaine's role in schizophrenia using metabolomics and genetic approaches, finding it may alleviate oxidative stress and improve cognitive function in specific cases.

EBioMedicine · Jun 26, 2019Peer-reviewedNeuroscience